1887

Abstract

Reports of unusual microorganisms causing human infections are on the rise due to transitions in epidemiological trends. Commensal/normal flora which are otherwise termed as ‘good bacteria’ are now causing infections in different group of patients, mostly immunocompromised individuals. Various host and environmental factors play a pivotal role in microbial transmigration from their normal habitat into the blood and other body sites. We report one such ‘good bacterium’ associated with sepsis in a patient who was given the same bacterium in the form of probiotics.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000097
2020-02-03
2024-04-28
Loading full text...

Full text loading...

/deliver/fulltext/acmi/2/4/acmi000097.html?itemId=/content/journal/acmi/10.1099/acmi.0.000097&mimeType=html&fmt=ahah

References

  1. Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis 2008; 46:S58–S61 [View Article]
    [Google Scholar]
  2. Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H et al. Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol 2017; 8:1490 [View Article]
    [Google Scholar]
  3. Gupta V, Garg R. Probiotics. Indian J Med Microbiol 2009; 27:202–209 [View Article]
    [Google Scholar]
  4. Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis . J Clin Microbiol 1998; 36:325–326 [View Article]
    [Google Scholar]
  5. Enterogermina, Bacillus clausii – Sanofi Patient information leaflet. https://www.enterogermina.in//media/EMS/Conditions/Consumer%20Healthcare/Brands/Enterogermina-India/Prodotti/pdf/product.pdf?la=en on: 16/08/2019
  6. CLSI Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; CLSI Guideline M45, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2015
    [Google Scholar]
  7. Gargar JD, Divinagracia RM. When good things go bad: a case series of bacteremia from probiotics. Chest 2019; 155:92A [View Article]
    [Google Scholar]
  8. Joshi S, Udani S, Sen S, Kirolikar S, Shetty A. Bacillus clausii septicemia in a pediatric patient after treatment with probiotics. Pediatr Infect Dis J 2019; 38:e228–e230 [View Article]
    [Google Scholar]
  9. Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in adults: how many blood cultures are needed?. J Clin Microbiol 2007; 45:3546–3548 [View Article]
    [Google Scholar]
  10. Baron EJ, Weinstein MP, Dunne WM, Yagupsky P, Welch DF. Cumitech 1C, Blood Cultures IV. Coordinating. In Baron EJ. editor 2005 Washington, DC: ASM Press; 2005
  11. Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006; 19:788–802 [View Article]
    [Google Scholar]
  12. Abbrescia A, Palese LL, Papa S, Gaballo A, Alifano P et al. Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation. Clinical Immunology, Endocrine & Metabolic Drugs 2015; 1:102–110 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000097
Loading
/content/journal/acmi/10.1099/acmi.0.000097
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error